Upcoming Events › Scientific event

Abliva will attend and present at the Mitochondria-Targeted Drug Development Summit in Boston, MA, USA. The event will be held on 22 - 24 February 2022. CEO Ellen Donnelly will be presenting in the session Patient-Focused Drug Development for Mitochondrial Disease. Synopsis: Highlighting the impact of patient input on research and development at Abliva Providing an overview of the multiple therapeutic options for mitochondrial disease being pursued at Abliva Presenting placebo controlled PMD patient data from our lead asset, KL1333